stella
beta
Venetoclax and CLAG-M for the Treatment of Acute Myeloid Leukemia and High-Grade Myeloid Neoplasms — Stella
Recruiting
Back to Acute Biphenotypic Leukemia trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
United States
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington
View full record on ClinicalTrials.gov